Tower Research Capital LLC (Trc) Cytom X Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 238 shares of CTMX stock, worth $252. This represents 0.0% of its overall portfolio holdings.

Number of Shares

238

Previous 17,039 98.6%

Holding current value

$252

Previous $20,000 100.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.12 - $1.51 $18,817 - $25,369	-16,801 Reduced 98.6%	238 $0
Q2 2024 Aug 13, 2024	BUY	$1.21 - $5.13 $20,617 - $87,410	17,039 New	17,039 $20,000
Q4 2023 Feb 13, 2024	SELL	$1.07 - $1.55 $1,120 - $1,622	-1,047 Reduced 12.72%	7,184 $11,000
Q3 2023 Nov 14, 2023	SELL	$1.26 - $1.87 $141 - $209	-112 Reduced 1.34%	8,231 $10,000
Q2 2023 Aug 14, 2023	SELL	$1.41 - $1.92 $52,181 - $71,055	-37,008 Reduced 81.6%	8,343 $14,000
Q1 2023 May 09, 2023	BUY	$1.48 - $2.88 $18,127 - $35,274	12,248 Added 37.0%	45,351 $69,000
Q4 2022 Feb 10, 2023	BUY	$1.19 - $1.91 $8,776 - $14,086	7,375 Added 28.67%	33,103 $53,000
Q3 2022 Nov 10, 2022	BUY	$1.23 - $1.97 $17,579 - $28,155	14,292 Added 124.97%	25,728 $37,000
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $20,378 - $38,491	-13,319 Reduced 53.8%	11,436 $21,000
Q1 2022 May 12, 2022	BUY	$2.67 - $4.68 $5,598 - $9,813	2,097 Added 9.26%	24,755 $66,000
Q4 2021 Feb 14, 2022	BUY	$3.87 - $7.39 $46,200 - $88,221	11,938 Added 111.36%	22,658 $98,000
Q3 2021 Nov 15, 2021	SELL	$4.32 - $6.43 $75,094 - $111,772	-17,383 Reduced 61.85%	10,720 $54,000
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $105,976 - $165,913	16,742 Added 147.36%	28,103 $178,000
Q1 2021 May 17, 2021	BUY	$6.6 - $9.0 $49,744 - $67,833	7,537 Added 197.1%	11,361 $88,000
Q4 2020 Feb 16, 2021	SELL	$6.47 - $7.9 $223,797 - $273,261	-34,590 Reduced 90.05%	3,824 $25,000
Q3 2020 Nov 16, 2020	BUY	$6.55 - $8.83 $148,396 - $200,052	22,656 Added 143.77%	38,414 $255,000
Q2 2020 Aug 13, 2020	BUY	$7.4 - $14.64 $116,609 - $230,697	15,758 New	15,758 $131,000
Q1 2020 May 15, 2020	SELL	$3.61 - $8.6 $13,920 - $33,161	-3,856 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$5.17 - $8.91 $11,384 - $19,619	2,202 Added 133.13%	3,856 $32,000
Q3 2019 Nov 05, 2019	BUY	$7.38 - $12.25 $5,756 - $9,555	780 Added 89.24%	1,654 $12,000
Q2 2019 Aug 13, 2019	BUY	$9.35 - $11.41 $8,171 - $9,972	874 New	874 $10,000
Q3 2018 Nov 13, 2018	SELL	$18.04 - $26.41 $631 - $924	-35 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$21.38 - $29.68 $38,120 - $52,919	-1,783 Reduced 98.07%	35 $1,000
Q1 2018 May 15, 2018	BUY	$21.76 - $34.22 $39,559 - $62,211	1,818 New	1,818 $52,000
Q4 2017 Feb 09, 2018	SELL	$19.0 - $23.09 $28,652 - $34,819	-1,508 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $20,403 - $27,400	1,508	1,508 $28,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Cytom X Therapeutics, Inc. Transaction History